(Q57163492)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

Jose Osmar Medina Pestana

9 February 2020

author

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Claudio José Struchiner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Guilherme Suarez-Kurtz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Ana Santoro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Claudia R Felipe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Helio Tedesco-Silva

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Elida B Ojopi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

1 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

1293-1303

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?

9 February 2020

cites work

1 reference

CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study

21 January 2018

1 reference

Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

21 January 2018

1 reference

Pharmacogenetics of calcineurin inhibitors in renal transplantation

21 January 2018

1 reference

CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation

21 January 2018

1 reference

Update on the clinical pharmacogenomics of organ transplantation

21 January 2018

1 reference

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.

21 January 2018

1 reference

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

21 January 2018

1 reference

The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.

21 January 2018

1 reference

Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians

21 January 2018

1 reference

Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients

21 January 2018

1 reference

Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients

21 January 2018

1 reference

Pharmacogenetics in the brazilian population

21 January 2018

1 reference

Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups

21 January 2018

1 reference

Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa

21 January 2018

1 reference

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

21 January 2018

1 reference

CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population

21 January 2018

1 reference

CYP3A5 genotypes and risk of oesophageal cancer in two South African populations

21 January 2018

1 reference

Polymorphism of antimalaria drug metabolizing, nuclear receptor, and drug transport genes among malaria patients in Zanzibar, East Africa

21 January 2018

1 reference

Functionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping tests

21 January 2018

1 reference

Distribution ofABCB1polymorphisms among Brazilians: impact of population admixture

21 January 2018

1 reference

An R2 statistic for fixed effects in the linear mixed model

21 January 2018

1 reference

Impact of population admixture on the distribution of theCYP3A5*3polymorphism

21 January 2018

1 reference

CYP3A5 genotype has no impact on plasma trough concentrations of lopinavir and ritonavir in HIV-infected subjects.

21 January 2018

1 reference

A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype.

21 January 2018

1 reference

Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients

21 January 2018

1 reference

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

21 January 2018

1 reference

Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients

21 January 2018

1 reference

Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem

21 January 2018

1 reference

Explaining variability in ciclosporin exposure in adult kidney transplant recipients

21 January 2018

1 reference

Population pharmacokinetic study of cyclosporine based on NONMEM in Chinese liver transplant recipients

21 January 2018

1 reference

Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation

21 January 2018

1 reference

Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids

21 January 2018

1 reference

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients.

21 January 2018

1 reference

Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients

21 January 2018

1 reference

The Implications of Population Admixture in Race-based Drug Prescription

21 January 2018

1 reference

Mixed-Effects Models in Sand S-PLUS

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.11.70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21806386%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference